Search Results - "Ullah, Sadna"

Study protocol: the ILANA study – exploring optimal implementation strategies for long-acting antiretroviral therapy to ensure equity in clinical care and policy for women, racially minoritised people and older people living with HIV in the UK – a qualitative multiphase longitudinal study design by Farooq, Hamzah Z, Apea, Vanessa, Kasadha, Bakita, Ullah, Sadna, Hilton-Smith, Gill, Haley, Amber, Scherzer, Jenny, Hand, James, Paparini, Sara, Phillips, Rachel, Orkin, Chloe M

“…IntroductionCabotegravir and rilpivirine (CAB+RPV long-acting (LA)) is recommended as a treatment for HIV-1 allowing people living with HIV to receive 2…”
Get full text

Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom? by Garvey, Lucy J, Cooke, Graham S, Smith, Colette, Stingone, Christoph, Ghosh, Indrajit, Dakshina, Subathira, Jain, Lakshmi, Waters, Laura J, Mahungu, Tabitha, Ferro, Filippo, Sood, Chandni, Freeman, Carolyn, Phillips, Clare, Dhairyawan, Rageshri, Burholt, Ruth, Sharp, Harriet, Ullah, Sadna, Gilleece, Yvonne, Brown, Ashley, Orkin, Chloe, Rodger, Alison, Bhagani, Sanjay

“…Abstract Background Modeling of the London hepatitis C virus (HCV) epidemic in men who have sex with men (MSM) and are living with human immunodeficiency virus…”
Get full text

Perspectives of people with HIV on implementing long acting cabotegravir plus rilpivirine in clinics and community settings in the UK: results from the anti-sexist, anti-racist, anti-ageist ILANA study by Orkin, Chloe, Hayes, Rosalie, Haviland, Joanne, Wong, Yuk Lam, Ring, Kyle, Apea, Vanessa, Kasadha, Bakita, Clarke, Emily, Byrne, Ruth, Fox, Julie, Barber, Tristan J, Clarke, Amanda, Paparini, Sara

“…The equity-focused ILANA study evaluated feasibility, acceptability, appropriateness of delivering on-label two-monthly cabotegravir and rilpivirine (CAB+RPV)…”
Get full text

Seroprevalence and demographic factors associated with hepatitis B, hepatitis C and HIV infection from a hospital emergency department testing programme, London, United Kingdom, 2015 to 2016 by Bundle, Nick, Balasegaram, Sooria, Parry, Sarah, Ullah, Sadna, Harris, Ross J, Ahmad, Karim, Foster, Graham R, Tong, Cheuk Yw, Orkin, Chloe

“…BackgroundProgress towards HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV) elimination requires local prevalence estimates and linkage to care (LTC)…”
Get full text

Decline in HCV incidence in HIV positive MSM - progress to HCV micro-elimination in the UK? by Garvey, Lucy, Cooke, Graham, Smith, Colette, Stingone, Christof, Ghosh, Indrajit, Dakshina, Subathira, Jain, Lakshmi, Waters, Laura Jane, Mahungu, Tabitha, Ferro, Filippo, Sood, Chandni, Freeman, Carolyn, Ullah, Sadna, Phillips, Clare, Sharp, Harriet, Burholt, Ruth, Dhairyawan, Rageshri, Gilleece, Yvonne, Brown, Ashley, Orkin, Chloe, Rodger, Alison, Bhagani, Sanjay

Get full text

AS039 - Decline in HCV incidence in HIV positive MSM - progress to HCV micro-elimination in the UK? by Garvey, Lucy, Cooke, Graham, Smith, Colette, Stingone, Christof, Ghosh, Indrajit, Dakshina, Subathira, Jain, Lakshmi, Waters, Laura Jane, Mahungu, Tabitha, Ferro, Filippo, Sood, Chandni, Freeman, Carolyn, Ullah, Sadna, Phillips, Clare, Sharp, Harriet, Burholt, Ruth, Dhairyawan, Rageshri, Gilleece, Yvonne, Brown, Ashley, Orkin, Chloe, Rodger, Alison, Bhagani, Sanjay

Get full text